With great respect I totally disagree.... this is a smart prudent business model that allows a highly competent team specializing in a critical area of healthcare not only to potentially provide returns to investors but crucially to also provide the necessary R&D funds to allow the development of further ground breaking infection control solutions to the global market. NAN is an Australian innovation success story and has huge potential. imho
It is the Consumables Stupid, page-35
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.62 |
Change
-0.080(2.16%) |
Mkt cap ! $1.098B | |||
| Open | High | Low | Value | Volume |
| $3.68 | $3.71 | $3.62 | $830.3K | 227.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4025 | $3.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.65 | 1310 | 3 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| NAN (ASX) Chart |